Rocket Pharmaceuticals Announces Participation at Upcoming Investor Conferences
August 30 2018 - 7:00AM
Business Wire
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a
leading U.S.-based multi-platform gene therapy company, today
announced that members of Rocket’s executive team will participate
in the following upcoming investor conferences:
- Citi’s 13th Annual Biotech Conference
on September 6, 2018 in Boston, MA
- Morgan Stanley 16th Annual Global
Healthcare Conference on September 13, 2018 at 5:15 p.m. Eastern
Time in New York, NY
A live audio webcast of the Morgan Stanley fireside chat will be
available on the Investors section of the company’s website,
www.rocketpharma.com. A replay of the presentation will be archived
on the Rocket website following the conference.
About Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”) is an
emerging, clinical-stage biotechnology company focused on
developing first-in-class gene therapy treatment options for rare,
devastating diseases. Rocket’s multi-platform development approach
applies the well-established lentiviral vector (LVV) and
adeno-associated viral vector (AAV) gene therapy platforms.
Rocket's lead clinical program is a LVV-based gene therapy for the
treatment of Fanconi Anemia (FA), a difficult to treat genetic
disease that leads to bone marrow failure and potentially cancer.
Preclinical studies of additional bone marrow-derived disorders are
ongoing and target Pyruvate Kinase Deficiency (PKD), Leukocyte
Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis
(IMO). Rocket is also developing an AAV-based gene therapy program
for an undisclosed rare pediatric disease. For more information
about Rocket, please visit www.rocketpharma.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180830005090/en/
Claudine Prowse, Ph.D.SVP, Corporate Strategy and IRORocket
Pharma, Inc.The Empire State Building, Suite 7530New York, NY
10118cp@rocketpharma.comwww.rocketpharma.cominvestors@rocketpharma.com
Rocket Pharmaceuticals (NASDAQ:RCKT)
Historical Stock Chart
From Apr 2024 to May 2024
Rocket Pharmaceuticals (NASDAQ:RCKT)
Historical Stock Chart
From May 2023 to May 2024